Skip to main content

Thalidomide victim Johanne Hebert speaks on the phone about her pain medication patch which is fixed to her back every three days at her home in Montreal, Quebec on November 14, 2014. The mother of a 28-year-old daughter has no arms and is on strong painkillers for chronic pain. (Michelle Siu for The Globe and Mail)

Michelle Siu/The Globe and Mail

Has there ever been a group more obviously deserving of government compensation than Canada's thalidomide survivors?

Damaged in the womb by a drug that Ottawa approved without proper study, they were born in the early 1960s with cruelly stunted limbs and other terrible malformations. Today, the 95 remaining victims are in their 50s, suffering increased pain and diminishing mobility related to their condition. They are beginning to require constant care. They need help, and they are asking Ottawa for it.

Yet the government's response has been to dodge the issue of responsibility and fire back platitudes. When The Globe and Mail asked Health Minister Rona Ambrose about the victims' deteriorating conditions and why she has so far turned down requests to meet with them (requests that date back to March), her office ignored the questions and instead tiresomely boasted that "Canada has one of the safest and most rigorous drug-approval systems in the world."

Story continues below advertisement

Ms. Ambrose's photo would not be out of place next to the dictionary definition of "cold comfort." Or perhaps that of "irony." The same unhelpful statement from her office acknowledged that it was the thalidomide scandal that "caused Health Canada to overhaul the Canadian drug-regulatory framework" in the first place and make it so rigorous today. Even the Minister's office knows the federal government failed to protect Canadians adequately. And still, nothing but banalities.

What is most extraordinary about the 95 Canadian "thalidomiders," as some of them call themselves, is that they have led such normal lives. They've married and had children; they've held down jobs. They've done so with deformed limbs, while suffering paralysis in parts of their bodies. Some are missing vital organs.


Read The Globe and Mail Special Report: After years of neglect, Canadian thalidomide survivors make a plea for help

Canada's thalidomide victims are resilient, but now time is catching up with them. New problems are emerging as they age. Standing for extended periods causes excruciating pain. They tire easily. Many who worked can no longer do so. Half of the remaining 95 rely on aging parents and friends for their care.

And why? Because Ottawa once told their pregnant mothers it was okay to take a problematic drug, the testing for which was so incomplete that the U.S. refused to approve it. These people have always been the indisputably innocent victims of an egregiously bad decision. There is no lingering question of moral responsibility. In a decent world, Ottawa would make the necessary payouts to the victims without hesitation.

In Germany, where the drug was invented and did the most damage, the government compensates 2,700 victims with annual pensions of as much as $110,000. We have the money to make the remaining years of our 95 thalidomide victims bearable and dignified. We should do it, and do it quickly.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter